These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pro-nociceptive effects of neuromedin U in rat. Yu XH; Cao CQ; Mennicken F; Puma C; Dray A; O'Donnell D; Ahmad S; Perkins M Neuroscience; 2003; 120(2):467-74. PubMed ID: 12890516 [TBL] [Abstract][Full Text] [Related]
25. Neuromedin U promotes human type 2 immune responses. Ye Y; Luo J; Zeng N; Jiang S; Chen W; Hoyle RD; Klenerman P; Pavord ID; Xue L Mucosal Immunol; 2022 May; 15(5):990-999. PubMed ID: 35810259 [TBL] [Abstract][Full Text] [Related]
26. Neuromedin U (NMU) regulates osteoblast differentiation and activity. Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362 [TBL] [Abstract][Full Text] [Related]
27. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Mitchell JD; Maguire JJ; Davenport AP Br J Pharmacol; 2009 Sep; 158(1):87-103. PubMed ID: 19519756 [TBL] [Abstract][Full Text] [Related]
28. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2. Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171 [TBL] [Abstract][Full Text] [Related]
29. Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation. Grippi C; Izzi B; Gianfagna F; Noro F; Falcinelli E; Di Pardo A; Amico E; Donati MB; de Gaetano G; Iacoviello L; Hoylaerts MF; Cerletti C Thromb Res; 2017 Nov; 159():100-108. PubMed ID: 29078099 [TBL] [Abstract][Full Text] [Related]
30. Epidermal Neuromedin U Attenuates IgE-Mediated Allergic Skin Inflammation. Mizukawa Y; Doi T; Yamazaki Y; Kudo A; Shiohara T PLoS One; 2016; 11(7):e0160122. PubMed ID: 27463114 [TBL] [Abstract][Full Text] [Related]
31. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice. Wang F; Zhang Y; Jiang X; Zhang Y; Zhang L; Gong S; Liu C; Zhou L; Tao J Cell Calcium; 2011 Jan; 49(1):12-22. PubMed ID: 21106238 [TBL] [Abstract][Full Text] [Related]
32. Neuromedin U Suppresses Collagen-Induced Arthritis through ILC2-Th2 Activation. Zhang Y; Qin Y; Chen Z J Immunol Res; 2021; 2021():5599439. PubMed ID: 33748288 [TBL] [Abstract][Full Text] [Related]
33. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway. Garczyk S; Klotz N; Szczepanski S; Denecke B; Antonopoulos W; von Stillfried S; Knüchel R; Rose M; Dahl E Oncotarget; 2017 May; 8(22):36246-36265. PubMed ID: 28423716 [TBL] [Abstract][Full Text] [Related]
34. Neuromedin U modulates neuronal excitability in rat hippocampal slices. Sasaki-Hamada S; Maeno Y; Yabe M; Ishibashi H Neuropeptides; 2021 Oct; 89():102168. PubMed ID: 34243110 [TBL] [Abstract][Full Text] [Related]
35. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis. Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q Front Immunol; 2021; 12():670676. PubMed ID: 33995408 [TBL] [Abstract][Full Text] [Related]
36. Does somatostatin confer insulinostatic effects of neuromedin u in the rat pancreas? Kaczmarek P; Malendowicz LK; Fabis M; Ziolkowska A; Pruszynska-Oszmalek E; Sassek M; Wojciechowicz T; Szczepankiewicz D; Andralojc K; Szkudelski T; Strowski MZ; Nowak KW Pancreas; 2009 Mar; 38(2):208-12. PubMed ID: 18948835 [TBL] [Abstract][Full Text] [Related]
37. Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin. Aizawa S; Sakata I; Nagasaka M; Higaki Y; Sakai T PLoS One; 2013; 8(7):e67118. PubMed ID: 23843987 [TBL] [Abstract][Full Text] [Related]
38. Nmur1-/- mice are not protected from cutaneous inflammation. Abbondanzo SJ; Manfra DJ; Chen SC; Pinzon-Ortiz M; Sun Y; Phillips JE; Laverty M; Vassileva G; Hu W; Yang S; Gustafson EL; Fine JS; Hedrick JA Biochem Biophys Res Commun; 2009 Jan; 378(4):777-82. PubMed ID: 19070594 [TBL] [Abstract][Full Text] [Related]
39. A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects. Inooka H; Sakamoto K; Shinohara T; Masuda Y; Terada M; Kumano S; Yokoyama K; Noguchi J; Nishizawa N; Kamiguchi H; Fujita H; Asami T; Takekawa S; Ohtaki T Bioorg Med Chem; 2017 Apr; 25(8):2307-2312. PubMed ID: 28291683 [TBL] [Abstract][Full Text] [Related]
40. Characterization of neuromedin U effects in canine smooth muscle. Westfall TD; McCafferty GP; Pullen M; Gruver S; Sulpizio AC; Aiyar VN; Disa J; Contino LC; Mannan IJ; Hieble JP J Pharmacol Exp Ther; 2002 Jun; 301(3):987-92. PubMed ID: 12023529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]